AQbD-guided development of a green RP-HPLC method for dual drug quantification in lipid–polymer hybrid nanoparticles for endometriosis therapy
This study developed a quality-by-design guided, green reversed-phase HPLC method for simultaneously quantifying two drugs within lipid-polymer hybrid nanoparticles designed for endometriosis treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (77)
- Angiogenesis and endometriosis via openalex
- Antiangiogenesis therapy for endometriosis via openalex
- Applications of nanomaterials in endometriosis treatment via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Inflammation and endometriosis via openalex
- Management of endometriosis-related infertility: Considerations and treatment options via openalex
- Mitigation of endometriosis using regenerative cerium oxide nanoparticles via openalex
- Nanoparticle-Assisted Combinatorial Therapy for Effective Treatment of Endometriosis via openalex
- Nanotechnologies for the detection and treatment of endometriosis via openalex
- Natural therapies assessment for the treatment of endometriosis via openalex
- Pathogenesis of Endometriosis: New Insights into Prospective Therapies via openalex
- Silibinin-induced endoplasmic reticulum stress and mitochondrial dysfunction suppress growth of endometriotic lesions via openalex
- Silymarin amplifies apoptosis in ectopic endometrial tissue in rats with endometriosis; implication on growth factor GDNF, ERK1/2 and Bcl-6b expression via openalex
- Statins: Is it New Weaponry against Endometriosis? via openalex
- Synergistic and protective effect of atorvastatin and amygdalin against histopathological and biochemical alterations in Sprague-Dawley rats with experimental endometriosis via openalex
- The Main Theories on the Pathogenesis of Endometriosis via openalex
- W2950256303 via openalex
- W3035028232 via openalex
- W3037274725 via openalex
- W3043660947 via openalex
- W3088578015 via openalex
- W3112437689 via openalex
- W3123286810 via openalex
- W3147896862 via openalex
- W3155551263 via openalex
- W3160163680 via openalex
- W3165294846 via openalex
- W3181172479 via openalex
- W3199859397 via openalex
- W3202177173 via openalex
- W4224277899 via openalex
- W4280645308 via openalex
- W4281621957 via openalex
- W4281647867 via openalex
- W4281747404 via openalex
- W4283787196 via openalex
- W4303982385 via openalex
- W4304099265 via openalex
- W4313826570 via openalex
- W4317871409 via openalex
- W4360603804 via openalex
- W4379880222 via openalex
- W4381332445 via openalex
- W4384827416 via openalex
- W4385789578 via openalex
- W4386098432 via openalex
- W4386705206 via openalex
- W4387691764 via openalex
- W4399009666 via openalex
- W4399287142 via openalex
- W4400226084 via openalex
- W4400800854 via openalex
- W4400976580 via openalex
- W4401716129 via openalex
- W4401750643 via openalex
- W4403789232 via openalex
- W4406028519 via openalex
- W4408919746 via openalex
- W4409572028 via openalex
- W4412901634 via openalex
- W1965258535 via openalex
- W4414030846 via openalex
- W1969200311 via openalex
- W1969560715 via openalex
- W1984433905 via openalex
- W1992985052 via openalex
- W2006541788 via openalex
- W2010976109 via openalex
- W2014451654 via openalex
- W2029713923 via openalex
- W2044813154 via openalex
- W2051749006 via openalex
- W2132587402 via openalex
- W2589912397 via openalex
- W2754055756 via openalex
- W2886327465 via openalex
- W2905315184 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-10-19T06:34:38.229974+00:00